3.4.22.43	aorta	expression in aorta valve, control valves and stenotic valves analyzed	683107	
3.4.22.43	aorta endothelium	cathepsin V localized to endothelial cells in areas rich of neovascularization	683107	
3.4.22.43	aortic endothelial cell	-	732502	
3.4.22.43	blood	-	707906	
3.4.22.43	brain	-	137271	
3.4.22.43	brain cortex	-	732049	
3.4.22.43	breast adenocarcinoma cell	ZR-75-1, Hs-578T, MDA-MB435	137271	
3.4.22.43	bronchoalveolar lavage fluid	from healthy subjects and Besnier-Boeck-Schaumann (BBS) disease patients, the latter show decreased cathepsin V concentrations, while contents of endostatin, an inhibitor of lung epithelial cells, are increased	752418	
3.4.22.43	bronchus	-	707906	
3.4.22.43	cardiomyocyte	-	753828	
3.4.22.43	colon	-	732591	
3.4.22.43	colonic cancer cell	-	669257	
3.4.22.43	colorectal cancer cell	-	732591	
3.4.22.43	commercial preparation	recombinant human cathepsin V for inhibition studies, N-terminal propeptide domains as inhibitors of cathepsin V	683207	
3.4.22.43	cornea	-	137270, 668472, 669257	
3.4.22.43	cornea	epithelium	668763	
3.4.22.43	cornea	normal and keratoconus corneas, the latter show a 1.5fold increased cathepsin V expression level, expression pattern, overview	669009	
3.4.22.43	endometrial cancer cell	-	731573	
3.4.22.43	endothelial cell	-	753117	
3.4.22.43	epidermis	-	668472, 709405, 752678	
3.4.22.43	epiglottis	-	707906	
3.4.22.43	epithelial cell	-	669754	
3.4.22.43	epithelium	thymic and corneal	668763	
3.4.22.43	esophagus	-	707906	
3.4.22.43	foot sole	-	707906	
3.4.22.43	gingiva	-	707906	
3.4.22.43	hair follicle	in the root sheath of the hair follicles	709405	
3.4.22.43	hair follicle	localization of the enzyme in the root sheets of the hair follicle	669754	
3.4.22.43	HCM cell	-	753828	
3.4.22.43	HCT-116 cell	-	732591	
3.4.22.43	heart	-	707906, 753828	
3.4.22.43	hippocampus	-	732049	
3.4.22.43	HUVEC cell	-	707626	
3.4.22.43	HUVEC cell	immunohistochemic enzyme analysis	753117	
3.4.22.43	HUVEC cell	plasminogen processing by cathepsin V, angiogenesis inhibition activity determined in	683210	
3.4.22.43	ileum	-	707906	
3.4.22.43	keratinocyte	-	752678	
3.4.22.43	kidney	-	707906	
3.4.22.43	liver	-	707906, 754753	
3.4.22.43	lung	-	752418	
3.4.22.43	lymph node	-	707906	
3.4.22.43	macrophage	-	732502	
3.4.22.43	macrophage	in plaque areas of diseased blood vessels, cathepsin expression levels during differentiation, overview	669257	
3.4.22.43	melanoma cell	-	752678	
3.4.22.43	additional information	no expression in colon, lung, trachea, ureter, testis, heart, muscle, aorta, spleen, and mammary gland	707906	
3.4.22.43	additional information	selective, tissue-specific expression	668472, 668763	
3.4.22.43	myocardium	-	753828	
3.4.22.43	pancreas	-	707906	
3.4.22.43	pancreatic islet cancer cell	-	707590	
3.4.22.43	PC-12 cell	-	732049	
3.4.22.43	pharynx	-	707906	
3.4.22.43	RKO cell	-	732591	
3.4.22.43	SK-N-MC cell	-	732049	
3.4.22.43	skin	-	669460, 707906	
3.4.22.43	skin	CTSV is highly expressed across the entire epidermis in normal skin. But CTSV expression levels are lower in the basal layer than those in the stratum corneum side in the hyperpigmented region	752678	
3.4.22.43	stomach	-	707906	
3.4.22.43	stratum corneum	-	669460	
3.4.22.43	stratum corneum	in extracellular space associated to corneodesmosomes, co-localization of the enzyme and inhibitor cystatin M/E	669754	
3.4.22.43	stratum granulosum	-	709405	
3.4.22.43	stratum granulosum	co-localization of the enzyme and inhibitor cystatin M/E, which are separately transported within lamellar granules	669754	
3.4.22.43	SW-480 cell	-	137271	
3.4.22.43	SW-620 cell	-	732591	
3.4.22.43	testis	-	137269, 137271, 668472, 668763, 669257	
3.4.22.43	THP-1 cell	-	732502, 754753	
3.4.22.43	thymic cortex	in the human thymic cortex, CTSV is the predominately expressed protease	707591	
3.4.22.43	thymus	-	137269, 137271, 668472, 669257	
3.4.22.43	thymus	epithelium	668763	
3.4.22.43	tongue	-	707906	
3.4.22.43	uterine endometrium	-	731573	
3.4.22.43	vocal fold	-	707906